Skip to main content

REPL Replimune Group, Inc.

Healthcare

21.98 USD 1D +0.20 +0.92% Close 11/12
Since 2024-12-11 +72.3%

Close 11/12

Open
21.32
High
22.10
Low
20.49
Prev close
21.78
Volume
2.89M
Amplitude
7.39%
P/B
10.1
52W 1.50 23.54
FinLab Studio

From Replimune Group, Inc. to every stock like it

AI finds several complementary traits of Replimune Group, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Replimune Group, Inc.

Is Replimune Group, Inc. a buy? Fundamentals and valuation first

As of 2026-11-11

Momentum: Strong; Valuation: Expensive, Quality: Weak.

Valuation Expensive Free-cash-flow yield is Average; Price / book is Expensive.
TTM P/E -7.8 N/A
Price / book 10.1 93th percentile · Expensive
Free-cash-flow yield (%) -11.9 27th percentile · Average
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Weak ROE, TTM is Lagging.
ROE, TTM (%) -132.4 9th percentile · Lagging
Operating margin, TTM (%) — N/A
FCF margin, TTM (%) — N/A
Quality Factor Investing: A US Quality Value Backtest
Growth Neutral Diluted EPS growth, TTM YoY is Average.
Revenue growth, TTM YoY (%) — N/A
Diluted EPS growth, TTM YoY (%) -22.5 45th percentile · Average
Momentum Strong All 2 indicators are Top.
60-day return (%) 39.8 97th percentile · Top
240-day return (%) 116.5 97th percentile · Top
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Neutral 20-day dollar volume is Top, but 60-day annualized volatility is Average.
20-day dollar volume 58,060,633.0 82th percentile · Top
60-day annualized volatility (%) 80.7 73th percentile · Average
Factor Investing Explained: 10 Classic Factors in US Stocks

Replimune Group, Inc. (REPL) today

2 quant signals active · As of 2026-11-11

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

Replimune Group, Inc. (REPL) peers and tracking

Watchlist

This page refreshes daily after the close. Add Replimune Group, Inc. to your watchlist to track signal changes on your next visit.

Replimune Group, Inc. (REPL) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

8 historical occurrences (since 2020-01-10)

Average forward return after 52-week adjusted-price high

20-day: Win 57.1%, Sample 7, Median +2.8%, Excess +4.4%, Beat mkt rate 57.1%

60-day: Win 71.4%, Sample 7, Median +9.6%, Excess +4.7%, Beat mkt rate 57.1%

120-day: Win 50.0%, Sample 6, Median +4.6%, Excess +11.7%, Beat mkt rate 50.0%

120 days after: historical avg +20.0%

20-day +6.8%
60-day +6.7%
120-day +20.0%
20-day
60-day
120-day
Win
57.1%
71.4%
50.0%
Sample
7
7
6
Median
+2.8%
+9.6%
+4.6%
Excess
+4.4%
+4.7%
+11.7%
Beat mkt rate
57.1%
57.1%
50.0%

Over 6 occurrences, 120-day forward avg gained 20.0%, beat the market by 11.7 pts; win rate 50.0%.

Top-quintile 6-month momentum

Active · now 99.9%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
18 historical occurrences (since 2019-04-05)

Average forward return after Top-quintile 6-month momentum

20-day: Win 50.0%, Sample 18, Median -3.0%, Excess -1.3%, Beat mkt rate 44.4%

60-day: Win 44.4%, Sample 18, Median -6.5%, Excess -2.3%, Beat mkt rate 38.9%

120-day: Win 52.9%, Sample 17, Median +1.7%, Excess +8.9%, Beat mkt rate 41.2%

120 days after: historical avg +16.9%

20-day -0.0%
60-day -0.6%
120-day +16.9%
20-day
60-day
120-day
Win
50.0%
44.4%
52.9%
Sample
18
18
17
Median
-3.0%
-6.5%
+1.7%
Excess
-1.3%
-2.3%
+8.9%
Beat mkt rate
44.4%
38.9%
41.2%

Over 17 occurrences, 120-day forward avg gained 16.9%, beat the market by 8.9 pts; win rate 52.9%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 101,110 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.32%, a 58.3% positive-return rate, and +2.99 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

9 times historically; 60-day forward avg +7.3%, win rate 62.5%, beating the market by +4.0 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.